About Fisher & Paykel Healthcare Corporation Limited (FPH)
Fisher & Paykel Healthcare Corporation Limited is a Medical Instruments & Supplies company operating in the Healthcare sector.
FPH trades on the Australian Securities Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- A$38.13
- Market Cap
- A$22.43B
- 52-Week High
- A$40.15
- 52-Week Low
- A$26.51
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
A$1,000 Invested in Fisher & Paykel Healthcare Corporation Limited (FPH)
How much would A$1,000 invested in FPH be worth today?
What would A$1,000 invested in FPH 1 year ago be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) in 2025 would be worth A$1,195 as of November 2026, representing a +19.6% total return.
What would A$1,000 invested in FPH 3 years ago be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) in 2023 would be worth A$2,086 as of November 2026, representing a +108.6% total return.
What would A$1,000 invested in FPH 5 years ago be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) in 2021 would be worth A$1,394 as of November 2026, representing a +39.4% total return.
What would A$1,000 invested in FPH 10 years ago be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) in 2016 would be worth A$5,353 as of November 2026, representing a +435.3% total return.
What would A$1,000 invested in FPH at IPO be worth today?
A A$1,000 investment in Fisher & Paykel Healthcare Corporation Limited (FPH) at IPO would be worth A$23,584 as of November 2026, representing a +2258.4% total return.
Monthly Returns Heatmap
Over the past 24+ years (299 months), Fisher & Paykel Healthcare Corporation Limited (FPH) has averaged a monthly return of +1.34% with a median return of +1.38%. The stock had 168 positive months (56%) and 125 negative months (42%). The best month in FPH's history was November 2022 with a +22.8% return, while the worst was February 2002 at -28.6%. Historically, November tends to be the strongest month (averaging +3.9%), and January the weakest (-1.6%).
FPH's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 2013 with a cumulative return of +63.3%, and the worst was 2002 at -32.5%.
Annual Returns
Over 25 years of trading history, Fisher & Paykel Healthcare Corporation Limited (FPH) has delivered an average annual return of +18.22% with a median return of +10.67%. The compound annual growth rate (CAGR) is +13.73%. The stock posted gains in 16 years (64%) and losses in 9 years (36%).
FPH's best year was 2013 with a +81.62% gain, while the worst was 2002 at -34.15%. The longest streak of consecutive positive years was 6, and the longest losing streak was 2 years. FPH achieved double-digit gains (10%+) in 13 years. It suffered double-digit losses in 5 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +17.79% | A$32.37 | A$38.13 |
| 2025 | -5.50% | A$34.25 | A$32.37 |
| 2024 | +62.13% | A$21.13 | A$34.25 |
| 2023 | +4.17% | A$20.28 | A$21.13 |
| 2022 | -28.96% | A$28.55 | A$20.28 |
| 2021 | -0.11% | A$28.58 | A$28.55 |
| 2020 | +48.02% | A$19.31 | A$28.58 |
| 2019 | +73.20% | A$11.15 | A$19.31 |
| 2018 | -2.19% | A$11.40 | A$11.15 |
| 2017 | +59.45% | A$7.15 | A$11.40 |
| 2016 | +0.08% | A$7.14 | A$7.15 |
| 2015 | +43.97% | A$4.96 | A$7.14 |
| 2014 | +69.97% | A$2.92 | A$4.96 |
| 2013 | +81.62% | A$1.61 | A$2.92 |
| 2012 | +10.67% | A$1.45 | A$1.61 |
| 2011 | -19.30% | A$1.80 | A$1.45 |
| 2010 | -14.81% | A$2.11 | A$1.80 |
| 2009 | +3.92% | A$2.03 | A$2.11 |
| 2008 | -8.17% | A$2.21 | A$2.03 |
| 2007 | -15.17% | A$2.61 | A$2.21 |
| 2006 | +13.97% | A$2.29 | A$2.61 |
| 2005 | +20.45% | A$1.90 | A$2.29 |
| 2004 | +38.11% | A$1.38 | A$1.90 |
| 2003 | +36.28% | A$1.01 | A$1.38 |
| 2002 | -34.15% | A$1.53 | A$1.01 |
Frequently Asked Questions: FPH
What sector is FPH in? ▼
FPH operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has FPH performed historically? ▼
Over 25 years of trading history, FPH has posted gains in 16 years (64% of the time). The best year was 2013 with a +81.6% return. Past performance does not guarantee future results.
How can I invest in FPH? ▼
You can invest in FPH through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold FPH.
Last updated: 11/1/2026